Latest DTU publications
-
A systematic review of in vivo brain insulin resistance biomarkers in humans
Journal article
Reid G. et al, (2025), Biomarkers in Neuropsychiatry, 12
-
Frailty in randomized controlled trials of glucose-lowering therapies for type 2 diabetes: An individual participant data meta-analysis of frailty prevalence, treatment efficacy, and adverse events.
Journal article
Wightman H. et al, (2025), PLoS Med, 22
-
Glucocorticoid-induced hyperglycaemia in hospitalised adults: A matched cohort study (2013-2023).
Journal article
Golubic R. et al, (2025), Diabetes Obes Metab
-
Response to Comments on Maddaloni et al. Osteoprotegerin, Osteopontin, and Osteocalcin Are Associated With Cardiovascular Events in Type 2 Diabetes: Insights From EXSCEL. Diabetes Care 2025;48:235-242.
Journal article
Maddaloni E. et al, (2025), Diabetes Care, 48, e61 - e62
-
Risk factors for bone fractures in type 2 diabetes and the impact of once-weekly exenatide: Insights from an EXSCEL post-hoc analysis.
Journal article
Maddaloni E. et al, (2025), Diabetes Res Clin Pract
-
Effects of intensive blood pressure treatment on orthostatic hypertension: individual level meta-analysis.
Journal article
Juraschek SP. et al, (2025), BMJ, 388
-
Identification of plasma proteomic markers underlying polygenic risk of type 2 diabetes and related comorbidities
Journal article
Loesch DP. et al, (2025), Nature Communications, 16
-
Effects of aspirin and omega-3 fatty acids on age-related macular degeneration in ASCEND-Eye: a randomised placebo-controlled trial in a population with diabetes.
Journal article
Sammons E. et al, (2025), BMJ Open, 15
-
A five-drug class model using routinely available clinical features to optimise prescribing in type 2 diabetes: a prediction model development and validation study.
Journal article
Dennis JM. et al, (2025), Lancet
-
Age and Sex Differences in Efficacy of Treatments for Type 2 Diabetes: A Network Meta-Analysis.
Journal article
Hanlon P. et al, (2025), JAMA
-
The Science of Diabetes and a Life of Trials: The 2024 Banting Medal for Scientific Achievement Award Lecture.
Journal article
Holman RR., (2025), Diabetes, 74, 164 - 174
-
Osteoprotegerin, Osteopontin, and Osteocalcin Are Associated With Cardiovascular Events in Type 2 Diabetes: Insights From EXSCEL.
Journal article
Maddaloni E. et al, (2025), Diabetes Care, 48, 235 - 242
-
Predictors of Cardiometabolic Health a Few Months Postpartum in Women Who Had Developed Gestational Diabetes
Journal article
Gómez Fernández C. et al, (2025), Nutrients, 17, 390 - 390
-
The legacy effect of hyperglycaemia in type 2 diabetes - Authors' reply.
Journal article
Adler AI. et al, (2025), Lancet, 405
-
Evaluating prediction of short-term tolerability of five type 2 diabetes drug classes using routine clinical features: UK population-based study
Journal article
Cardoso P. et al, (2025), Diabetes Obesity and Metabolism
-
Long-term outcomes following alternative second-line oral glucose-lowering treatments: Results from the real-world progression in type 2 diabetes mellitus United Kingdom (RAPIDS-UK) model
Journal article
Carroll OU. et al, (2025), Diabetes Obesity and Metabolism
-
Comparative effectiveness of alternative second-line oral glucose-lowering therapies for type 2 diabetes: a precision medicine approach applied to routine data
Journal article
O’Neill S. et al, (2025), Diabetologia
-
An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders
Journal article
De Giorgi R. et al, (2025), Nature Mental Health
-
Cardiovascular Risk Prediction Scores in Type 1 Diabetes: A Systematic Review and Meta-Analysis
Journal article
Erqou S. et al, (2025), JACC: Advances, 4
-
Great debate: pre-diabetes is not an evidence-based treatment target for cardiovascular risk reduction.
Journal article
Marx N. et al, (2024), Eur Heart J, 45, 5117 - 5126
About DTU
About DTU
Our People
Our Studies
CONTACT US
Phone: +44 (0)1865 857240
Email: dtu@dtu.ox.ac.uk